col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


33 Results       Page 1

 [1] 
Springer-Verlag: Journal of Neuroimmune Pharmacology
  original article Date Title Authors   All Authors
1 [GO] 2021―Dec―22 The Neuroimmune Pharmacology of SARS-CoV-2 Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack, Gurudutt Pendyala, Sanjay Maggirwar, Sulie L. Chang
2 [GO] 2021―Dec―11 Correction to: Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID Erin Clough, Joseph Inigo, Dhyan Chandra, Lee Chaves, Jessica L. Reynolds, Ravikumar Aalinkeel, et al. (+3)
3 [GO] 2021―Nov―30 Melatonin: Revisited Role as Vaccine Adjuvant During Outbreaks of COVID-19 Caused by the Delta Variant Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
4 [GO] 2021―Nov―26 The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings Jean M. Bidlack, Sulie L. Chang, Sylvia Fitting, Howard E. Gendelman, Santhi Gorantla, Santosh Kumar, et al. (+5)
5 [GO] 2021―Nov―10 Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection Ryan C. Camacho, Sedra Alabed, Heping Zhou, Sulie L. Chang
6 [GO] 2021―Oct―23 SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation Brandon J. DeOre, Kiet A. Tran, Allison M. Andrews, Servio H. Ramirez, Peter A. Galie
7 [GO] 2021―Oct―22 Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses Ramesh Kumar Paidi, Malabendu Jana, Sumita Raha, Mary McKay, Monica Sheinin, Rama K. Mishra, Kalipada Pahan
8 [GO] 2021―Oct―16 Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications Jag H. Khalsa, Sanjay B. Maggirwar, Greg Bunt
9 [GO] 2021―Oct―04 Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID Erin Clough, Khoo Ting Chean, Joseph Inigo, Kate E. Tubbesing, Dhyan Chandra, Lee Chaves, et al. (+5)
10 [GO] 2021―Sep―09 Racial Health Disparity and COVID-19 Santosh Kumar, Prashant Kumar, Sunitha Kodidela, Benjamin Duhart, Alina Cernasev, Anantha Nookala, et al. (+3)
11 [GO] 2021―Aug―24 Investigating Neurological Manifestations of SARS-CoV-2 Maryam Mozafar, Seyed Amir Mirmotalebisohi, Marzieh Sameni, Hakimeh Zali
12 [GO] 2021―Jun―28 Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop Santosh Kumar, Gurudutt Pendyala, Sowmya V. Yelamanchili, Pankaj Seth, Sanjay Maggirwar, Jean M. Bidlack, Sulie L. Chang
13 [GO] 2021―May―28 The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections Kevin Roe
14 [GO] 2021―May―18 Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals Marco Cosentino, Marco Ferrari, Franca Marino
15 [GO] 2021―Feb―05 A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, et al. (+21)
16 [GO] 2021―Feb―03 Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? Adriano José Maia Chaves Filho, Franciane Gonçalves, Melina Mottin, Carolina Horta Andrade, Silvia Nunes Szente Fonseca, Danielle S. Macedo
17 [GO] 2021―Jan―18 Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome Júlia Leão Batista Simões, Margarete Dulce Bagatini
18 [GO] 2021―Jan―11 ACE-2-interacting Domain of SARS-CoV-2 (AIDS) Peptide Suppresses Inflammation to Reduce Fever and Protect Lungs and Heart in Mice: Implications for COVID-19 Therapy Ramesh K. Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Sumita Raha, Kalipada Pahan
19 [GO] 2021―Jan―06 Is COVID-19 Gender-sensitive? Shreya Mukherjee, Kalipada Pahan
20 [GO] 2021―Jan―06 Pharmacotherapeutics of SARS-CoV-2 Infections Bhavesh D. Kevadiya, Jatin Machhi, Jonathan Herskovitz, Maxim D. Oleynikov, Wilson R. Blomberg, Neha Bajwa, et al. (+14)
21 [GO] 2021―Jan―06 SARS-COV2 Alters Blood Brain Barrier Integrity Contributing to Neuro-Inflammation Jessica. L. Reynolds, Supriya D. Mahajan
22 [GO] 2021―Jan―04 Correction to: Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? Francesco Benedetti, Mario Gennaro Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini
23 [GO] 2020―Oct―26 Can Cytokine Blocking Prevent Depression in COVID-19 Survivors? Francesco Benedetti, Mario Mazza, Giulio Cavalli, Fabio Ciceri, Lorenzo Dagna, Patrizia Rovere-Querini
24 [GO] 2020―Sep―15 Infectivity of SARS-CoV-2: there Is Something More than D614G? Saathvik R. Kannan, Austin N. Spratt, Thomas P. Quinn, Xiao Heng, Christian L. Lorson, Anders Sönnerborg, et al. (+2)
25 [GO] 2020―Sep―10 Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla
26 [GO] 2020―Sep―10 Does Adding of Hydroxychloroquine to the Standard Care Provide any Benefit in Reducing the Mortality among COVID-19 Patients?: a Systematic Review Tejas K. Patel, Manish Barvaliya, Bhavesh D. Kevadiya, Parvati B. Patel, Hira Lal Bhalla
27 [GO] 2020―Jul―21 The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, Debashis Dutta, Barnali Nath, Maxim D. Oleynikov, et al. (+9)
28 [GO] 2020―Jun―29 Clomipramine Could Be Useful in Preventing Neurological Complications of SARS-CoV-2 Infection B. Nobile, M. Durand, E. Olié, S. Guillaume, J. P. Molès, E. Haffen, P. Courtet
29 [GO] 2020―Jun―25 Comment on “Smooth or Risky Revisit of an Old Malaria Drug for COVID-19?” Erkan Cure, Medine Cumhur Cure, Adem Kucuk
30 [GO] 2020―Jun―11 May the Central Nervous System Be Fogged by the Cytokine Storm in COVID-19?: an Appraisal Yasin Hasan Balcioglu, Umit Haluk Yesilkaya, Hasan Gokcay, Simge Seren Kirlioglu
31 [GO] 2020―May―23 SARS-CoV-2 Infection Leads to Neurological Dysfunction Arpan Acharya, Bhavesh D. Kevadiya, Howard E. Gendelman, Siddappa N. Byrareddy
32 [GO] 2020―May―15 Smooth or Risky Revisit of an Old Malaria Drug for COVID-19? Priyanka Pahan, Kalipada Pahan
33 [GO] 2020―May―07 Feasibility of Therapeutic Effects of the Cholinergic Anti-Inflammatory Pathway on COVID-19 Symptoms Roham Mazloom
 [1] 

33 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec